Deep Medicine Acquisition Corp. (DMAQ) は上場企業です 金融 セクターの Shell Companies 業界で事業展開. 本社所在地は New York City, NY, アメリカ. 現CEOは Humphrey P. Polanen.
DMAQ を有する IPO日 2021-12-02, 2 名の正社員, に上場 NASDAQ Global Market, 時価総額 $12.9M.
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.
